FDA Direct: Combating Rare Diseases at the FDA
Join FDA Commissioner Marty Makary and Director of the Office of the Secretariat Elisabeth Armstrong as they talk with FDA Chief of Staff Jim Traficant about the impact rare disease has had on his life, and how his lived experiences are contributing to innovation at the FDA.
▶︎
FDA Direct - Special Edition of FDA Direct
▶︎
FDA Direct: The Power of Real-Time Clinical Trials
▶︎
FDA Direct: Catching Up on Agency Reforms
▶︎
Medical Device Quality Management System Regulation Risk Management
▶︎
FDA Direct: What's the Deal with Talc? - Recapping
▶︎
Ebola Survivor - Dr. Ian Crozier
▶︎
CDER & CBER All Hands: Implementing the FDA's Plausible Mechanism Framework
▶︎
FDA Direct: To Boost or Not to Boost - Gathering New Evidence on Covid Boosters
▶︎
FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)
▶︎
FDA Direct: No One Think It's a Good Idea for Kids to Consume Petroleum Products
▶︎
FDA Direct: Who Buys the Spin — Hook, Line and Sinker?
▶︎
FDA Direct: FDA is Not Your Doctor - Discussing FDA's Role and Mandate
▶︎
FDA Direct: Faster Reviews, Food Dye Wins and Protecting American DNA
▶︎
FDA Grand Rounds - Clinical Omics Biomarker Discovery and Validation in Precision Medicine
▶︎
FDA Direct: Dramatically lowering drug prices for Americans
▶︎
CDRH Patient Education Program: Patients as Advisors in Medical Device Clinical Studies
▶︎
FDA Direct, Striking a Balance - Framework for Future Covid-19 Vaccine Decisions
▶︎
OTP Town Hall: Best Practices for Preparing BLA Submissions for Cell and Gene Therapy Products
▶︎
FDA Direct: These 9 Drugs Were Awarded National Priority Vouchers
▶︎